The NYSE suspended trading in Mallinckrodt (MNK +10.1%) pending the release of news.
Update: The company has agreed in principle to settle “Track 1” opioid cases in Ohio by paying $24M in cash plus $6M of donated generic products, including meds to treat opioid addiction.
Update: Shares are up 13% on resumption of trade.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.